We serve Chemical Name:4-Chloro-1H-indazole CAS:102735-85-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Chloro-1H-indazole
CAS.NO:102735-85-3
Synonyms:4-chloroindazole-3-carboxaldehyde;4-CHLORO-1H-INDAZOLE-3-CARBALDEHYDE;4-CHLORO (1H)INDAZOLE;4-Chloro-3-(1H)Indazole carboxaldehyde;4-Chloro-1H-indazole;1H-Indazole, 4-chloro-;4-Chloro-3-(1h)indazole carbaldehyde
Molecular Formula:C7H5ClN2
Molecular Weight:152.581
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:309.5±15.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.703
PSA:28.68000
Exact Mass:152.014130
LogP:2.41
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-chloroindazole-3-carboxaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Chloro-3-(1h)indazole carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-3-(1h)indazole carbaldehyde Use and application,4-chloroindazole-3-carboxaldehyde technical grade,usp/ep/jp grade.
Related News: Other possible health risks of PFAS include kidney cancer, testicular cancer and high blood pressure, the researchers added. 4-Chloro-1H-indazole manufacturer Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management, Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said. 4-Chloro-1H-indazole supplier Other possible health risks of PFAS include kidney cancer, testicular cancer and high blood pressure, the researchers added. 4-Chloro-1H-indazole vendor The company��s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients. 4-Chloro-1H-indazole factory Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.
